fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Pfizer Ltd

Pfizer Ltd

Updated on November 23, 2020

Stock/Share Code - PFIZER

Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products.(Source : 201903 Annual Report Page No: 131)

Below is the details of PFIZER Pfizer Ltd

Market Cap₹21,027 Cr.
Current Price ₹5,104.5 as on 27 Nov 20
52 Week High / Low Price₹5,172.95 / ₹2,905.05
Face Value₹10
Stock P/E40.38
Book Value₹742.22
Dividend Yield0.22 %
ROCE20.42 %
ROE15.92 %
Sales Growth (3yrs)3.05 %
SectorPharmaceuticals
IndustryPharmaceuticals - Multinational
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has delivered good profit growth of 38.52% CAGR over last 5 years Company has been maintaining a healthy dividend payout of 115.31%
Cons: The company has delivered a poor growth of 3.04% over past five years.

Pfizer Ltd Price Chart

Pfizer Ltd Price Chart

Pfizer Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Abbott India ₹290.4 53.02 ₹34,801.34 Cr. 0.65 ₹180.35 Cr. 54.22 6.55 1064.27 35.18
2. Glaxosmi. Pharma ₹58.95 64.27 ₹26,534.07 Cr. 1.28 ₹110.83 Cr. -2.39 -17.69 648.59 32.88
3. Pfizer 40.38 ₹21,026.57 Cr. 0.22 ₹124.45 Cr. 10.32 -5.42 514.89 20.42
4. Sanofi India ₹8,267.35 36.70 ₹18,927.32 Cr. 1.28 ₹136.3 Cr. 39.16 -5.00 710.50 28.38
5. Astrazeneca Phar ₹4,538.9 128.00 ₹8,874.38 Cr. 0.06 ₹18.63 Cr. -13.43 -5.37 193.58 33.92
6. P & G Health Ltd ₹3.8 48.40 ₹7,962.94 Cr. 0.00 ₹46.46 Cr. 14.12 -1.26 228.11 19.89
7. Novartis India ₹290.4 112.15 ₹1,534.16 Cr. 1.61 ₹4.39 Cr. 455.70 -15.41 92.46 4.53

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Pfizer Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -571457520512520514536544567538502515
YOY Sales Growth %6.63%-7.09%18.69%21.71%-8.99%12.54%3.02%6.26%9.10%4.75%-6.28%-5.42%
Expenses -404339381382390359385378403405393329
Material Cost %41.92%35.79%37.33%36.00%39.04%34.41%34.31%35.09%36.93%37.31%38.08%34.49%
Employee Cost %13.89%14.37%17.04%15.74%15.01%16.29%15.21%16.10%15.21%16.72%20.05%16.68%
Operating Profit167118138130130154151166164133109186
OPM %29%26%27%25%25%30%28%31%29%25%22%36%
Other Income243231313764353645584517
Interest00-0000123243
Depreciation161817181818182525252827
Profit before tax175132153142149201168175181164122173
Tax %36%34%31%35%36%34%35%36%15%15%16%28%
Net Profit111871059296132109113154139103124
EPS in Rs24.2919.0722.8420.0720.9428.8423.9324.6633.7230.4022.5227.20
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -6747721,2521,0931,0491,1121,8532,0121,9661,9692,0822,1522,122
Sales Growth %0.36%14.57%62.18%-12.71%-4.07%5.99%66.66%8.63%-2.29%0.11%5.74%3.37%
Expenses -5496449838978658721,4381,5791,6161,4681,5161,5781,530
Material Cost %35.25%37.26%31.18%32.85%31.76%33.72%39.94%39.11%40.51%37.58%35.93%36.83%
Manufacturing Cost %4.84%6.28%6.00%5.92%6.07%5.67%4.43%3.76%3.92%3.50%3.55%3.03%
Employee Cost %15.60%18.14%18.37%17.67%20.16%17.28%12.78%13.81%15.49%16.00%15.60%16.99%
Other Cost %25.72%21.75%22.93%25.57%24.45%21.80%20.50%21.80%22.27%17.49%17.74%16.48%
Operating Profit125128270197184239414433350501566574593
OPM %19%17%22%18%18%22%22%22%18%25%27%27%28%
Other Income3049089925191094497232114167183165
Interest002221212121112
Depreciation11812108825058636671103105
Profit before tax419210345278694340207470517548660642641
Tax %29%35%34%33%27%35%66%35%35%34%35%21%
Net Profit29913722618550322170305337360429509521
EPS in Rs98.1243.7554.8859.84163.0912.8312.7266.6673.6178.7093.78111.29113.84
Dividend Payout %12%27%22%20%19%486%82%22%27%25%24%297%

Compounded Sales Growth

  • 10 Years:: 10.79%
  • 5 Years:: 3.04%
  • 3 Years:: 3.05%
  • TTM:: 0.40%

Compounded Profit Growth

  • 10 Years:: 13.52%
  • 5 Years:: 38.52%
  • 3 Years:: 26.23%
  • TTM:: 15.72%

Return on Equity

  • 10 Years:: 15.31%
  • 5 Years:: 14.45%
  • 3 Years:: 36.38%
  • 1 Year:: 57.07%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -303030303030464646464646
Equity Capital29.8429.8429.8429.8429.8429.8445.7545.7545.7545.7545.7545.75
Reserves8709641,1341,2751,6656291,9272,1182,3732,6372,9663,350
Borrowings000000222222
Other Liabilities -1972092232773653186387228401,0049261,007
Trade Payables10711698136151160334338388496436427
Advance from Customers000000299154180179179
Other liability items8993125141214158302285297329311402
Total Liabilities1,0961,2031,3861,5822,0609772,6142,8883,2613,6903,9404,405
Fixed Assets -519236312620944925902950886973
Gross Block1401881181181161151,2899811,0211,1331,1381,315
Accumulated Depreciation89958287909534456119182252342
CWIP321200313315101
Investments004948464443370000
Other Assets -1,0131,1101,3001,5021,9889091,6141,9232,3432,7393,0543,432
Inventories125113159183165152388361322297387431
Trade receivables6064100142142173160142110155172172
Cash Equivalents5435275788661,4333086091,0251,5231,7721,9142,220
Loans n Advances28840837117810487172194185269318277
Other asset items-3-491133143189285202204246263332
Total Assets1,0961,2031,3861,5822,0609772,6142,8883,2613,6903,9404,405

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -237758024-1613211334532933298323
Profit from operations161176282208195252299451363515580589
Receivables-7-18-53-59-34-14-342718-45-19-2
Inventory-3012-46-24-1414-79273925-91-44
Payables29133221391583061110-593
Other WC items071606-10-111531-79-76-9
Working capital changes-813-50-62-35-406914910-245-52
Direct taxes-127-103-149-122-208-124-145-174-183-194-238-213
Exceptional CF items211-11-3-000000000
Cash from Investing Activity --79-475727862610368-701-250-238351,530
Fixed assets purchased-27-19-7-3-1-4-21-44-25-103-4-17
Fixed assets sold2110424209791333137
Investments purchased-108-910000000000
Subsidy received0000320000000
Investment income000000094778
Interest received54628581769839567990121140
Invest in subsidiaries000-000000000
Inter corporate deposits00-21199870000000
Other investing items01007649-819-399-266-1191,363
Cash from Financing Activity --95-43-86-14-43-1,360-1-62-83-110-110-164
Interest paid fin00000000000-0
Dividends paid-95-43-86-14-21-1,161-1-50-69-92-91-103
Financial liabilities00000000000-39
Other financing items0000-23-1990-12-14-19-19-21
Net Cash Flow63-1651288567-1,125181-417-3-17231,690

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Nov 2008Nov 2009Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %27%23%32%23%19%29%24%22%17%21%23%20%
Debtor Days323029474957322620293029
Inventory Turnover2.232.492.932.151.962.422.782.132.362.432.221.97

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Pfizer Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.